ALFA FinderBSE filing, NSE: ASMTEC. Summary written from the filing by ALFA Finder's alert engine.
ASM Technologies Ltd: key numbers
- Share price
- ₹6,249.85
- Market cap
- ₹9,118 Cr
- Revenue (annual)
- ₹528.5 Cr
- Net profit (annual)
- ₹60.76 Cr
- P/E (TTM)
- 109.1×Sector 23.7×
- Promoter holding
- 53.49%-4.16% QoQ
- FII holding
- 1.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ASM Technologies Ltd
All →ASM Technologies Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹268 Cr (+74% YoY), EBITDA ₹59 Cr (22.0% margin), PAT ₹30.7 Cr (+60%). H1 revenue ₹467 Cr (+68%). Strategy: DLM capacity expansion funded by ₹526 Cr preferential issue.
ASM Technologies Dividend
ASM Technologies' board declared an interim dividend of ₹6 per equity share on November 7, 2026. Record date is November 16, 2026, with payment by December 5, 2026.
ASM Technologies Financial Results
ASM Technologies approved unaudited standalone and consolidated results for the quarter ended 30 September 2026 and declared a second interim dividend of Rs. 6 per share. Record date is 16 November 2026, with payment on or before 5 December 2026.
ASM Technologies Q2 FY27 Results: Net Profit ₹34.5 Cr, Up 80.6% YoY
ASM Technologies approved Q2 FY27 unaudited standalone and consolidated results and declared a second interim dividend of Rs. 6 per share. Payment is due by 5 December 2026, with record date 16 November 2026.
- Key figure
- Net profit ₹34.5 Cr · +80.6% YoY
ASM Technologies Board Meeting Date
ASM Technologies has scheduled a Board meeting on November 7, 2026, to consider Q2 FY27 results and interim dividend. Insider trading window stays closed through November 12.
ASM Technologies Other Announcement
ASM Technologies Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI Regulation 31.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr